Role of Interleukin-1 in Abnormal Monocyte Phenotype in Systemic Onset Juvenile Idiopathic Arthritis

被引：0
|
作者：
Zhang, Yujuan [1 ]
Macaubas, Claudia [1 ]
Klein, Clarissa [1 ]
Pascual, M. Virginia [2 ]
Hay, Arielle [3 ]
Thompson, Susan D. [4 ]
Sandborg, Christy I. [1 ]
Ilowite, Norman T. [3 ]
Mellins, Elizabeth D. [1 ]
机构：
[1] Stanford Univ, Med Ctr, Stanford, CA 94305 USA
[2] Baylor Inst Immunol Res, Dallas, TX USA
[3] Childrens Hosp Montefiore, Bronx, NY USA
[4] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
来源：
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2188
引用
收藏
页码：S932 / S933
页数：2
相关论文
共 50 条
  • [31] Serum Biomarkers in a German Cohort of Patients with Systemic Juvenile Idiopathic Arthritis and Their Relationship to Response to Interleukin-1 Blockade
    Hinze, Claas
    Hinze, Tanja
    Wittkowski, Helmut
    Kessel, Christoph
    Fuehner, Sabrina
    Foell, Dirk
    ARTHRITIS & RHEUMATOLOGY, 2020, 72 : 239 - 240
  • [32] Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis
    Sota, Jurgen
    Insalaco, Antonella
    Cimaz, Rolando
    Alessio, Maria
    Cattalini, Marco
    Gallizzi, Romina
    Maggio, Maria Cristina
    Lopalco, Giuseppe
    La Torre, Francesco
    Fabiani, Claudia
    Pardeo, Manuela
    Olivieri, Alma Nunzia
    Sfriso, Paolo
    Salvarani, Carlo
    Gaggiano, Carla
    Grosso, Salvatore
    Bracaglia, Claudia
    De Benedetti, Fabrizio
    Rigante, Donato
    Cantarini, Luca
    FRONTIERS IN PHARMACOLOGY, 2019, 9
  • [33] Fatal myocarditis in a child with systemic onset juvenile idiopathic arthritis during treatment with an interleukin 1 receptor antagonist
    Andrew S Zeft
    Shaji C Menon
    Dylan Miller
    Pediatric Rheumatology, 10
  • [34] Fatal myocarditis in a child with systemic onset juvenile idiopathic arthritis during treatment with an interleukin 1 receptor antagonist
    Zeft, Andrew S.
    Menon, Shaji C.
    Miller, Dylan
    PEDIATRIC RHEUMATOLOGY, 2012, 10
  • [35] Biologicals acting against interleukin 1 may reduce corticosteroid dependence in systemic onset juvenile idiopathic arthritis
    W Emminger
    A Ulbrich
    E Pernetzky-Hintringer
    Pediatric Rheumatology, 9 (Suppl 1)
  • [36] Evaluation of Patients with Systemic onset Juvenile Idiopathic Arthritis
    Cekic, Sukru
    Karali, Yasin
    Kilic, Sara Sebnem
    GUNCEL PEDIATRI-JOURNAL OF CURRENT PEDIATRICS, 2019, 17 (02): : 279 - 289
  • [37] MEFV mutations in systemic onset juvenile idiopathic arthritis
    Ayaz, N. A.
    Ozen, S.
    Bilginer, Y.
    Erguven, M.
    Taskiran, E.
    Yilmaz, E.
    Besbas, N.
    Topaloglu, R.
    Bakkaloglu, A.
    RHEUMATOLOGY, 2009, 48 (01) : 23 - 25
  • [38] Preseptal cellulitis in systemic onset Juvenile Idiopathic Arthritis
    A G A Coombes
    A Zaman
    M Hall
    M I D Cawley
    Eye, 2003, 17 : 258 - 260
  • [39] Preseptal cellulitis in systemic onset juvenile Idiopathic Arthritis
    Coombes, AGA
    Zaman, A
    Hall, M
    Cawley, MID
    EYE, 2003, 17 (02) : 258 - 260
  • [40] PHAGOCYTE INVOLVEMENT IN SYSTEMIC ONSET JUVENILE IDIOPATHIC ARTHRITIS
    ter Haar, N. M.
    de Jager, W.
    Scholman, R. S.
    Meerding, J.
    Tak, T.
    Leliefeld, P. H. C.
    Vastert, S. J.
    de Roock, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : A3 - A3
12345